Site Editor

Soo Park, MD

Advertisement

Advertisement

News

Novel Compound Targeting Skin Cancer–Associated HPV5 Identified for Antiviral Drug Development

Medical Literature

Avelumab Plus Cetuximab Improves Progression-Free Survival in Advanced cSCC

News

ASCO 2025: Frequency and Types of Targetable Mutations in Cutaneous Skin Cancers

News

ASCO 2025: Primary Results From the RELATIVITY-098 Trial in Completely Resected Melanoma

News

Molecular Profile of Japanese Patients With Advanced Melanoma

Medical Literature

Are Adult Survivors of Childhood Cancer at Increased Risk for Melanoma?

News

Can Macrophage Activity Predict Immunotherapy Response in Patients With Melanoma?

Ahmad Tarhini, MD, PhD, on High-Risk Resectable Melanoma: Neoadjuvant Therapies

Carlo M. Contreras, MD, FACS, on Novel Therapies for Skin Cancers: A Surgical Perspective

View More

Advertisement

JNCCN Spotlights

(NEW) Cemiplimab Combination Treatment for Solid Organ Transplant Recipients

Cemiplimab-rwlc in Cutaneous Squamous Cell Carcinoma

(UPDATE) Cemiplimab in Cutaneous Squamous Cell Carcinoma

Cetuximab (Erbitux®) – (Non-Melanoma Skin Cancers)

Avelumab (Bavencio)

View More

More

News

AACR 2025: AI Models May Help Diagnose Nonmelanoma Skin Cancers in Resource-Limited Regions

Can Macrophage Activity Predict Immunotherapy Response in Patients With Melanoma?

Prognostic Factors Seem to Favor Women in Global Study of Patients With Cutaneous Melanoma

ASCO 2025: Primary Results From the RELATIVITY-098 Trial in Completely Resected Melanoma

Mohs Surgery vs Wide Local Excision in cSCC

Novel Compound Targeting Skin Cancer–Associated HPV5 Identified for Antiviral Drug Development

AACR 2025: What Role Do Potentially Modifiable Risk Factors Play in the Burden of MCC?

Antithrombotic Therapy Concomitant With Immunotherapy in Advanced Melanoma

View More

Advertisement

Published

Medical Literature

Risk Prediction Calculator From Australia Under Study in Stage II Melanoma

Can New AI Tool Help to Distinguish Melanomas From Benign Skin Lesions? Swedish Researchers Say Yes

Do Race and Sex Play a Role in Nonmetastatic Melanoma?

Are Patients Being Treated for Psoriasis at Risk for Skin Cancer?

View More

Ongoing

CE Activities

Updates to the Management of Cutaneous Melanoma

A Case From the Real World: Treating Advanced Melanoma as Part of the Interdisciplinary Team

Case Series: Defining the Role of Immunotherapy Across Melanoma Care

Delivering Equitable, Patient-Centered Care in Advanced Melanoma

View More

Available

Clinical Trials

Phase 2 Study of Afatinib in Advanced Cutaneous Squamous Cell Carcinoma

Double-Blind Study of Adjuvant Cemiplimab Vs Placebo After Surgery and Radiation Therapy in Patients With High Risk Cutaneous Squamous Cell Carcinoma

Neoadjuvant Atezolizumab in Surgically Resectable Advanced Cutaneous Squamous Cell Carcinoma

A Phase 1B/2 Study of RP1 in Solid Organ Transplant Patients With Advanced Cutaneous Malignancies

View More

Resources

For Your Patients

AIM at Skin Cancer Offers Clinician Guidance on Patient Resources and Education

Mayo Clinic - Skin Cancer

American Cancer Society - Skin Cancer Fact Sheet

Water’s Edge Dermatology

View More

Sections

360 Hub

NCCN Resources

Copyright^© 2025 National Comprehensive Cancer Network, All Rights Reserved